Page results
-
Information about making a donation to the Haematology Cancer Care charity fund at UCLH
-
SUMMIT Study results on the benefits of large-scale screening for lung cancer are published in The Lancet Oncology today (26 March), ahead of the formal addition of lung cancer screening to the UK national screening programme from 1 April.
-
A breathing aid that can help keep Covid-19 patients out of intensive care, adapted by mechanical engineers at UCL and clinicians at UCLH working with Mercedes-AMG High Performance Powertrains (Mercedes-AMG HPP), has been approved for use in the NHS.
-
Dr. Patrick Murphy is a principal clinical neuropsychologist at the National Hospital for Neurology and Neurosurgery
-
Breakthroughs in Alzheimer’s disease are exciting and invigorating dementia research, and we will need to be ready to deliver new treatments as they come through, say Professor Nick Fox and Dr Catherine Mummery.
-
UCLH-led research paper outlines mechanism behind rare cases of blood clots and low platelets after vaccination
-
Medtronic are running a series of patient webinars for anyone with Type 1 Diabetes using the MiniMed™ 780G pump or system.
-
A study of patients at UCLH and North Middlesex University Hospital published in The Lancet Infectious Diseases suggests that the B.1.17. variant of Covid-19 is not associated with more severe illness and death, but appears to lead to higher virus load.
-
New precision therapy for bile duct cancer extends patients’ lives
-
The musculoskeletal (MSK) outpatient therapy service at University College Hospital provides assessment and treatment of patients for a variety of specialities including orthopaedic, rheumatology, hand therapy, women’s health, orthotic, podiatry and spinal non-operative and operative patients with musculoskeletal dysfunction.
File results
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0210 - Top five drugs that expired by value
-
FOI/2023/0214 - Patients waiting over 78 weeks for elective care
-
FOI/2023/0215 - British sign language procurement and communications
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment
-
FOI/2023/0227 - Number of radiographers and nuclear medicine clinical scientists at Trust
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0124 - Clinical decision support in e-prescribing, Observations vital signs, Oncology e-prescribing and Diagnostic imaging systems